Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
TAIPEI, Aug. 4, 2025 /PRNewswire/ — Anbogen Therapeutics today announced that the U.S. Food and Drug Administration…
TAIPEI, Aug. 4, 2025 /PRNewswire/ — Anbogen Therapeutics today announced that the U.S. Food and Drug Administration…
BEIJING, Aug. 3, 2025 /PRNewswire/ — Raytone Biotech, a clinical-stage biotechnology company dedicated to inno…
BEIJING, Aug. 4, 2025 /PRNewswire/ — Raytone Biotech, a biotechnology company dedicated to innovative ophthalm…
AMSTERDAM, Aug. 4, 2025 /PRNewswire/ — OCI Global (Euronext: OCI), ("OCI," the "Company") …
HONG KONG, Aug. 4, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announc…
BEIJING, Aug. 4, 2025 /PRNewswire/ — Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"),…
KUALA LUMPUR, Malaysia, Aug. 4, 2025 /PRNewswire/ — The countdown has begun. With just one week to go, Kind Malaysi…
Pioneering solution provides scientists with actionable answers faster to accelerate scientific discovery COLUMBUS, Ohio,…
FWD Group, YCH Group, and The Hong Kong Jockey Club to be recognized for aligning their technology and business strategie…
SINGAPORE, Aug. 4, 2025 /PRNewswire/ — Students from disadvantaged families will now have a boost to receive higher…
SHANGHAI, Aug. 4, 2025 /PRNewswire/ — From March 29th to April 3rd, 2026, Tourism Plus Shanghai (TPS 2026) wil…
KUALA LUMPUR, Malaysia, Aug. 4, 2025 /PRNewswire/ — RHB Banking Group ("RHB" or the "Group") en…
SHENZHEN, China, Aug. 4, 2025 /PRNewswire/ — Elegoo, a rapidly developing brand in global smart manufacturing,…
SUZHOU, China, Aug. 4, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the Investigation…
SINGAPORE, Aug. 4, 2025 /PRNewswire/ — People Intelligence Singapore Pte. Ltd. ("Omni HR") today announce…
Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies …